Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"Eurofarma Laboratorios S.A","sponsor":"Summit Therapeutics","pharmaFlowCategory":"D","amount":"$3.8 million","upfrontCash":"Undisclosed","newsHeadline":"Summit Therapeutics to Receive $1.0 Million Milestone Payment","therapeuticArea":"Infections and Infectious Diseases","highestDevelopmentStatus":"Phase III","country":"BRAZIL","productType":"Small molecule","productStatus":"New Molecular Entity","date":"February 2020","url1":"","url2":"","graph1":"Infections and Infectious Diseases","graph2":"Phase III"},{"orgOrder":0,"company":"Eurofarma Laboratorios S.A","sponsor":"Pacira BioSciences","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Pacira BioSciences Signs Exparel Distribution Agreement With Eurofarma in Latin America","therapeuticArea":"Neurology","highestDevelopmentStatus":"Approved","country":"BRAZIL","productType":"Small molecule","productStatus":"Approved","date":"June 2021","url1":"","url2":"","graph1":"Neurology","graph2":"Approved"},{"orgOrder":0,"company":"Eurofarma Laboratorios S.A","sponsor":"SK Biopharmaceuticals","pharmaFlowCategory":"D","amount":"$62.0 million","upfrontCash":"$15.0 million","newsHeadline":"SK Biopharmaceuticals, Eurofarma Enter into Licensing Agreement for Cenobamate in Latin America","therapeuticArea":"Neurology","highestDevelopmentStatus":"Approved","country":"BRAZIL","productType":"Small molecule","productStatus":"Approved","date":"July 2022","url1":"","url2":"","graph1":"Neurology","graph2":"Approved"}]

    Find Clinical Drug Pipeline Developments & Deals by Eurofarma Laboratorios S.A

    Menu

    Eurofarma Laboratorios S.A

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              Eurofarma Laboratorios S.A

              Contact Supplier
              • Deals
              Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
              Post an Enquiry Post an Enquiry
              Flag Brazil
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              SK Biopharmaceuticals, Eurofarma Enter into Licensing Agreement for Cenobamate in Latin America

              Details:

              Under the terms of agreement, SK Biopharmaceuticals has granted Eurofarma the exclusive rights to develop and commercialize Xcopri (cenobamate) in Latin America. SK Biopharmaceuticals will now be present in four continents: North America, Europe, Asia, and Latin America.

              Lead Product(s): Cenobamate

              Therapeutic Area: Neurology Product Name: Xcopri

              Highest Development Status: Approved Product Type: Small molecule

              Recipient: SK Biopharmaceuticals

              Deal Size: $62.0 million Upfront Cash: $15.0 million

              Deal Type: Licensing Agreement July 14, 2022

              ASK
              US
              PHARMACOMPASS
              Upload
              your Pipeline Activity

              Eurofarma Laboratorios S.A

              Contact Supplier
              • Deals
              Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
              Post an Enquiry Post an Enquiry
              Flag Brazil
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Pacira BioSciences Signs Exparel Distribution Agreement With Eurofarma in Latin America

              Details:

              Under the terms of the agreement, Eurofarma obtains the exclusive right to market and distribute EXPAREL in 19 countries in Latin America, including Argentina, Brazil, Colombia, and Mexico.

              Lead Product(s): Bupivacaine

              Therapeutic Area: Neurology Product Name: Exparel

              Highest Development Status: Approved Product Type: Small molecule

              Recipient: Pacira BioSciences

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Agreement June 22, 2021

              ASK
              US
              PHARMACOMPASS
              Upload
              your Pipeline Activity

              Eurofarma Laboratorios S.A

              Contact Supplier
              • Deals
              Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
              Post an Enquiry Post an Enquiry
              Flag Brazil
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Summit Therapeutics to Receive $1.0 Million Milestone Payment

              Details:

              The milestone payment was initiated by Summit achieving its initial patient enrolment target at trial sites in Latin America in the Phase 3 clinical trials of ridinilazole for C. difficile infection.

              Lead Product(s): Ridinilazole

              Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

              Highest Development Status: Phase III Product Type: Small molecule

              Recipient: Summit Therapeutics

              Deal Size: $3.8 million Upfront Cash: Undisclosed

              Deal Type: Collaboration February 06, 2020

              ASK
              US
              PHARMACOMPASS
              Upload
              your Pipeline Activity
              Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
              One Pharma aims to be one of the leading generic companies in Europe.
              Post Enquiry
              POST ENQUIRY